Skip to content

US Physical Therapy USPH Gain Loss On Sale Of Partnership

Gain Loss On Sale Of Partnership at other companies

Air Products and Chemicals logo
Air Products and ChemicalsAPD
$1.8M-18.2%
Intercontinental Exchange logo
Intercontinental ExchangeICE
$389M
Constellation Brands logo
Constellation BrandsSTZ
$0-100%
eBay logo
eBayEBAY
$31M+1,650%
Citizens Financial Group logo
Citizens Financial GroupCFG
$7M-22.2%
Universal Health Services logo
Universal Health ServicesUHS
$5.05M

Other financials

Income statement

See full
Revenue$198.3M+7.9%
Gross profit$32.8M+5.4%
Operating income$12.5M-36.5%
Net income$5.0M-49.1%
EPS (diluted)-$0.12-115%

Balance sheet

See full
Cash & equivalents$28.4M-27.4%
Total debt$169.4M+12.6%
Total equity$469.0M-5.7%
Total assets$1.2B+5.3%

Cash flow

See full
Operating cash flow$3.8M+181%
CapEx$5.4M+108%
Free cash flow-$1.6M+78.4%

Valuation

See full
Market cap$1.01B-10.6%
Enterprise value$1.15B-7.2%
P/E29×-4.8×
P/S1.3×-0.3×

Profitability

See full
Gross margin19%+0.9pp
Operating margin10%+0.3pp
Net margin4.4%-0.4pp
FCF margin8.4%+0.4pp

Returns & leverage

See full
Return on equity7.2%+0.4pp
Debt / equity0.4×+0.1×
Current ratio1.2×0.0×

Where this comes from

Reported directly by US Physical Therapy in its filing.

Tagged under the XBRL concept usph:GainLossOnSaleOfPartnership.

The official record: US Physical Therapy’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about US Physical Therapy's gain loss on sale of partnership.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is US Physical Therapy's gain loss on sale of partnership?
US Physical Therapy (USPH) reported gain loss on sale of partnership of $0 in Q1 2026.
How has US Physical Therapy's gain loss on sale of partnership changed year-over-year?
US Physical Therapy's gain loss on sale of partnership increased by 100.0% year-over-year, from -$123K to $0.
What does gain loss on sale of partnership mean?
This captures the realized gain or loss resulting from the divestiture of an interest in a partnership or joint venture. It serves as an indicator of the company's ability to monetize its strategic investments at a premium.